CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CLIO project focuses on developing advanced imaging technologies for real-time detection of cancerous tissues during surgery. By utilizing Cerenkov luminescence imaging, it aims to improve surgical outcomes and reduce the risk of cancer recurrence post-surgery.
Cancer is the second largest cause of death and morbidity in Europe, with more than 3 million new cases diagnosed each year.
The most effective treatment strategy for most forms of cancer is early detection followed by surgery.
However, cancers frequently recur following surgery.
For example, nearly 1 in 4 breast cancer patients will see their tumour recur after surgery.
The consequences of cancer recurrence include repeat operations, delayed adjuvant treatment, increased likelihood of distant r…
CROMED KUTATO ES SZOLGALTATO KOZPONTOK KFT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, DRESDEN
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, CHESHAM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, HARSTON, CAMBRIDGE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
